
On 7 September 2026, UKC Tuzla updated its information about medicines that had not been supplied to the institution by the Federation of Bosnia and Herzegovina Health Insurance Fund by that date. The official list names idarubicin, mitoxantrone, vinblastine 10 mg, pemetrexed 500 mg, letrozole 2.5 mg and abiraterone 500 mg.
The list is a snapshot for a specific date and may change after a new delivery. Patients using one of the listed treatments should confirm availability with the relevant UKC Tuzla clinic or their treating doctor before attending.
Treatment should not be stopped, changed or postponed without medical advice. Treatment decisions must be made with the responsible doctor, and the latest position should always be checked in the official source.